Krishna Yeshwant, Director at Foundation Medicine, holds 12.17M shares in Verve Therapeutics (Ticker: VERV), holds 0.00 shares in Foundation Medicine (Ticker: FMI), holds ― shares in EQRx, Inc. (Ticker: EQRX). Most recently, Krishna Yeshwant Bought ― shares of Verve Therapeutics on Dec 05, 2023 for an estimated value of 18.00M.